CRWM
ABBV icon

Castle Rock Wealth Management’s AbbVie ABBV Stock Holding History

Castle Rock Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
1,515
+17
+1% +$3.66K 0.07% 196
2026
Q1 		$313K Sell
1,498
-67
-4% -$14.9K 0.07% 215
2025
Q4 		$355K Buy
1,565
+6
+0.4% +$1.37K 0.08% 199
2025
Q3 		$371K Buy
1,559
+10
+0.6% +$2.04K 0.08% 187
2025
Q2 		$288K Sell
1,549
-3,534
-70% -$657K 0.07% 213
2025
Q1 		$1.06M Sell
5,083
-2,055
-29% -$400K 0.29% 95
2024
Q4 		$1.38M Buy
7,138
+341
+5% +$62.7K 0.33% 87
2024
Q3 		$1.32M Buy
6,797
+119
+2% +$22.2K 0.32% 90
2024
Q2 		$1.14M Buy
6,678
+205
+3% +$34K 0.28% 100
2024
Q1 		$1.05M Buy
6,473
+431
+7% +$74.3K 0.29% 106
2023
Q4 		$977K Sell
6,042
-47
-0.8% -$6.85K 0.3% 91
2023
Q3 		$905K Buy
6,089
+2,511
+70% +$369K 0.3% 83
2023
Q2 		$492K Buy
3,578
+194
+6% +$28.4K 0.17% 128
2023
Q1 		$497K Buy
3,384
+15
+0.4% +$2.29K 0.18% 125
2022
Q4 		$497K Sell
3,369
-196
-5% -$30.1K 0.22% 122
2022
Q3 		$504K Buy
+3,565
New +$512K 0.25% 106
2020
Q3 		– Sell
-6,029
Closed -$569K – 163
2020
Q2 		$569K Buy
6,029
+1,757
+41% +$155K 0.33% 103
2020
Q1 		$384K Sell
4,272
-4,797
-53% -$409K 0.33% 79
2019
Q4 		$871K Buy
9,069
+751
+9% +$62.3K 0.78% 40
2019
Q3 		$713K Buy
8,318
+866
+12% +$59.4K 0.74% 42
2019
Q2 		$545K Buy
+7,452
New +$586K 0.6% 60
2018
Q4 		– Sell
-4,719
Closed -$395K – 10
2018
Q3 		$395K Sell
4,719
-30
-0.6% -$2.85K 0.63% 54
2018
Q2 		$440K Buy
4,749
+791
+20% +$77.3K 0.6% 63
2018
Q1 		$375K Sell
3,958
-1,153
-23% -$127K 0.62% 57
2017
Q4 		$494K Buy
+5,111
New +$482K 0.96% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Castle Rock Wealth Management's ABBV Position: Q2 2026 in Review

Castle Rock Wealth Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $3.66K and bringing the position to 1,515 shares worth $380K. The position accounts for 0.07% of the portfolio, ranked #196.

Castle Rock Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 25 quarters since. The position peaked at $1.38M in Q4 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Castle Rock Wealth Management held 1,515 shares of AbbVie worth $380K as of Q2 2026.
  • Castle Rock Wealth Management bought 17 AbbVie shares in Q2 2026, an estimated $3.66K.
  • AbbVie made up 0.07% of Castle Rock Wealth Management's portfolio in Q2 2026, its #196 holding.
  • Castle Rock Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 25 quarters since.
  • Castle Rock Wealth Management's AbbVie position peaked at $1.38M in Q4 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Castle Rock Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.